Hey, Get Out of My Space
Executive Summary
Chemdex Corp., a leading supplier of reagents and other products to laboratories and pharmaceutical R&D departments has acquired Promedix.com, a provider of purchasing services in high-tech, physician-preferred medical devices. With Chemdex's market cap soaring towards $1.5 billion, Promedix investors have seen their deal value increase over 50% beyond the $340 million at which it was first valued. The strategic rationale for this and similar kinds of deals is less obvious.You may also be interested in...
Health And Wellness Trademark Review 14 January, 2020
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention
Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.
Deal Watch: Novo Nordisk, Fauna To Explore Hibernation To Treat Obesity
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports